FILTER RESULTS
FILTER RESULTS
close.svg
Search Result for “Mohammad Abu Hajar”

Showing 1 - 10 of 66

OPINION

Shah controversy

Oped, Postbag, Published on 14/01/2026

» Re: "If Iran's supreme leader falls, who's next?", (World, Dec 22). Whilst I applaud the Iranian people and their courage in trying to depose the cruel, medieval ayatollahs and their stone age regime, I cannot understand why the demonstrators are calling for the restoration of the monarchy headed by Reza Pahlavi, the son of the Shah, whom they deposed in 1979.

OPINION

Echoes of Hiroshima

Published on 08/08/2025

» Re: "Japan needs true vision of peace", (Opinion, July 31).

OPINION

In the 'kingdom of silence', the caged bird raps

Oped, Mohammad Abu Hajar, Published on 18/07/2025

» In Syria, the caged bird raps. On my first night imprisoned, I began to write:

OPINION

Israel hits hard and fast to stop Iranian threat

News, John J. Metzler, Published on 21/06/2025

» Well, it seems to have started. Israeli airstrikes on Iran's nuclear research and development sites have ushered in a new phase of the Middle East conflicts, which began when Tehran's Hamas terrorist proxies invaded Israel on Oct 7, 2023, murdering 1,200 people and taking 254 hostages.

OPINION

Gulf spectacle masks strategic shift in US policy

Oped, John J Metzler, Published on 22/05/2025

» With the showmanship of a Cecil B De Mille saga, President Donald Trump's state visit to three Arab kingdoms was uniquely paired with pomp and joint business incentives that focused on transforming the narrative from conflict to commerce and cooperation. The visits were set to the spectacular backdrop of casts of thousands, Arabian stallions, and camel cohorts marking the fanfare of the president's four-day trip to the region.

OPINION

Unite to solve neglected diseases

Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025

» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.

OPINION

Sudan's hell of devastation and despair

Oped, John J. Metzler, Published on 24/04/2025

» The Four Horsemen of the Apocalypse are stalking Sudan: brutal civil conflict, widespread devastation, humanitarian disasters, and the displacement of millions of refugees. Now add the Fifth Horseman, the darkness of global indifference.

OPINION

Taliban rule dims Afghan women's rights

News, John J. Metzler, Published on 17/03/2025

» The darkening rule of the Taliban regime over Afghanistan continues to dim prospect women's rights as well as any chances for the war-torn country to overcome an ongoing humanitarian catastrophe. Currently more than 50 percent of the population, some 23 million people in this South Asian land, require humanitarian assistance and that aid is now decreasing.

OPINION

What did we miss in run-up to Assad's ouster?

News, Slavoj Žižek, Published on 23/12/2024

» The downfall of Bashar al-Assad's regime in Syria surprised even the opposition, led by Abu Mohammad al-Jolani's Hayat Tahrir al-Sham, offering fertile ground for conspiracy theories.

OPINION

Lockerbie bombing and the questions that linger

Oped, Kantathi Suphamongkhon, Published on 20/12/2024

» I often wondered how much of our lives are predetermined by forces beyond our comprehension.